Caldan Therapeutics is a pioneering brand specializing in the discovery of innovative therapeutics for metabolic diseases. Their main focus is on developing solutions for Type 2 Diabetes, as well as non-alcoholic steatohepatitis (NASH) and inflammatory diseases. With a team that boasts strong academic expertise and extensive experience in GPCR drug discovery and development, Caldan Therapeutics is at the forefront of advancing research in this field.

They leverage their knowledge of GPCR targets to create activators of free fatty acid receptors, a key area of interest for combating Type 2 Diabetes. Located in Edinburgh, Caldan Therapeutics is committed to making a difference in the lives of those affected by metabolic diseases. For more information or to get in touch, you can reach them via email at info@caldantherapeutics.

co. uk. Visit their website to learn more about their programs and achievements in the field of therapeutics